FDA Inspection 1038412 — David O'Malley, MD

David O'Malley, MD — FEI 3013976843

The FDA completed an inspection of David O'Malley, MD on January 23, 2018 in Columbus, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 23, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbus, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
755221 CFR 312.66Changes in research
756021 CFR 312.60FD-1572, protocol compliance